Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00637897

Completed

Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT00458588

Completed

Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children

Breast Cancer
NCT01762020

Completed

Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation

Breast Cancer | Dermatitis
NCT00828074

Completed

Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer

Breast Cancer
NCT00045591

Terminated

Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer

Breast Cancer
NCT00849459

Completed

Gene Therapy in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT01708798

Terminated

Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer

Breast Cancer
NCT00006007

Completed

LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT00005963

Completed

Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT00008320

Completed

Ceramide Cream in Treating Women With Cutaneous Breast Cancer

Breast Cancer
NCT01508273

Completed

Lifestyle Intervention for High Risk Cancer Survivors

Breast Cancer
NCT02759549

Withdrawn

Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH

Breast Cancer
NCT01156961

Withdrawn

A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)

Breast Cancer
NCT02553850

Completed

An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)

Breast Cancer
NCT00811135

Completed

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

Breast Cancer
NCT00692458

Withdrawn

A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)

Breast Cancer
NCT02627703

Unknown

(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer

Breast Cancer
NCT00004893

Completed

Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer

Breast Cancer
NCT01166763

Completed

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

Breast Cancer
NCT00249015

Completed

Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors

Breast Cancer
NCT00003854

Completed

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Breast Cancer
NCT00012025

Completed

ICI 182780 in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT01080170

Completed

The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer (Silhouette)

Breast Cancer
NCT00248170

Completed

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer (FACE)

Breast Cancer
NCT02707835

Unknown

Edema Control in Patients With Breast Cancer-comparison of Manual Lymph Drainage and Epidermis Fascia Taping

Breast Cancer
NCT01427166

Completed

Non-Invasive Imaging for Cording in Breast Cancer Patients

Breast Cancer
NCT00010010

Completed

Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer

Breast Cancer
NCT01819948

Completed

Changes in Biomarkers of Cancer in Women With Breast Cancer and Without Evidence of Disease Who Were Given PhytoMed™

Breast Cancer
NCT00020722

Terminated

Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

Breast Cancer
NCT00753207

Completed

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

Breast Cancer
NCT00573755

Terminated

Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer

Breast Cancer
NCT00540800

Completed

BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer (BREAST-10)

Breast Cancer
NCT00039286

Completed

Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer

Breast Cancer
NCT00216047

Terminated

PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer

Breast Cancer
NCT02050620

Completed

Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast Cancer

Breast Cancer
NCT00693719

Completed

Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer

Breast Cancer
NCT01880645

Completed

Selective Image Guided Resection of Axillary Lymph Nodes

Breast Cancer
NCT01068704

Completed

Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer

Breast Cancer
NCT00166543

Completed

Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer

Breast Cancer
NCT01506466

Completed

Weight Variation During Chemotherapy in Breast Cancer Patients

Breast Cancer
NCT01403168

Terminated

Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in Oncology (OSTEOPATHIE)

Breast Cancer
NCT00929240

Completed

A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer

Breast Cancer
NCT00712569

Completed

Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety

Breast Cancer
NCT01290718

Terminated

A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.

Breast Cancer
NCT00960336

Completed

Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer

Breast Cancer
NCT01928615

Terminated

A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (LISAH)

Breast Cancer
NCT02003560

Active, not recruiting

Accelerated Partial Breast Irradiation With 3D-CRT and IMRT (APERT)

Breast Cancer | Radiation Toxicity | Side Effects
NCT01335152

Completed

Online Stress Management and Coping Skills Training for Women With Breast Cancer

Breast Cancer
NCT01392066

Completed

Psychosocial Adjustment of Patients and Their Partners Following Breast Cancer Diagnosis

Breast Cancer
NCT00003066

Unknown

Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations